Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 1606 AL 1620

New Pathways Identify Novel Drug Targets for the Prevention and Treatment of Alzheimer's Disease

Penke B, Szűcs M, Bogár F.

Int J Mol Sci. 2023 Mar 11;24(6):5383. doi: 10.3390/ijms24065383.

Cardiovascular Risk Management in Persons with Dementia

Nijskens C, Henstra M, Rhodius-Meester H, Yasar S, van Poelgeest E, Peters M, Muller M.

J Alzheimers Dis. 2023;93(3):879-889. doi: 10.3233/JAD-230019.

Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond

Webber EK, Fivaz M, Stutzmann GE, Griffioen G.

Alzheimers Dement. 2023 Aug;19(8):3701-3717. doi: 10.1002/alz.13065. Epub 2023 May 3.

Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial

Altomare D, Barkhof F, Caprioglio C, Collij LE, Scheltens P, Lopes Alves I, Bouwman F, Berkhof J, van Maurik IS, Garibotto V, Moro C, Delrieu J, Payoux P, Saint-Aubert L, Hitzel A, Molinuevo JL, Grau-Rivera O, Gispert JD, Drzezga A, Jessen F, Zeyen P, Nordberg A, Savitcheva I, Jelic V, Walker Z, Edison P, Demonet JF, Gismondi R, Farrar G, Stephens AW, Frisoni GB; Amyloid Imaging to Prevent Alzheimer’s Disease (AMYPAD) Consortium.

JAMA Neurol. 2023 Jun 1;80(6):548-557. doi: 10.1001/jamaneurol.2023.0997.

An updated overview of recent and ongoing deep brain stimulation (DBS) trials in patients with dementia: a systematic review

Remoli G, Tariciotti L, Remore LG, Palmisciano P, Sciancalepore F, Canevelli M, Lacorte E, Da Re F, Bruno G, Ferrarese C, Appollonio I, Locatelli M, Vanacore N.

Neurol Sci. 2023 Oct;44(10):3395-3427. doi: 10.1007/s10072-023-06821-w. Epub 2023 May 19.

The Effects of Medium Chain Triglyceride for Alzheimer's Disease Related Cognitive Impairment: A Systematic Review and Meta-Analysis

Sun L, Ye KX, Wong HLK, Wang L, Lim SL, Chao YX, Zhang C, Yap KZ, Feng L.

J Alzheimers Dis. 2023;94(2):441-456. doi: 10.3233/JAD-230406.

Turning the Spotlight to Cholinergic Pharmacotherapy of the Human Language System

Dávila G, Torres-Prioris MJ, López-Barroso D, Berthier ML.

CNS Drugs. 2023 Jul;37(7):599-637. doi: 10.1007/s40263-023-01017-4. Epub 2023 Jun 21.

Differential response to donepezil in MRI subtypes of mild cognitive impairment

Diaz-Galvan P, Lorenzon G, Mohanty R, Mårtensson G, Cavedo E, Lista S, Vergallo A, Kantarci K, Hampel H, Dubois B, Grothe MJ, Ferreira D, Westman E.

Alzheimers Res Ther. 2023 Jun 23;15(1):117. doi: 10.1186/s13195-023-01253-2.

Caffeine for Prevention of Alzheimer's Disease: Is the A(2A) Adenosine Receptor Its Target?

Merighi S, Travagli A, Nigro M, Pasquini S, Cappello M, Contri C, Varani K, Vincenzi F, Borea PA, Gessi S.

Biomolecules. 2023 Jun 8;13(6):967. doi: 10.3390/biom13060967.

Outcomes and clinical implications of intranasal insulin on cognition in humans: A systematic review and meta-analysis

Wu S, Stogios N, Hahn M, Navagnanavel J, Emami Z, Chintoh A, Gerretsen P, Graff-Guerrero A, Rajji TK, Remington G, Agarwal SM.

PLoS One. 2023 Jun 28;18(6):e0286887. doi: 10.1371/journal.pone.0286887. eCollection 2023.

The complex pathway between amyloid β and cognition: implications for therapy

Jagust WJ, Teunissen CE, DeCarli C.

Lancet Neurol. 2023 Sep;22(9):847-857. doi: 10.1016/S1474-4422(23)00128-X. Epub 2023 Jul 13.

Donanemab for Alzheimer Disease-Who Benefits and Who Is Harmed?

Manly JJ, Deters KD.

JAMA. 2023 Aug 8;330(6):510-511. doi: 10.1001/jama.2023.11704.

Effect of acupuncture on episodic memory for amnesia-type mild cognitive impairment: study protocol of a multicenter, randomized, controlled trial

Dai Y, Xia R, Wang D, Li S, Yuan X, Li X, Liu J, Wang M, Kuang Y, Chen S.

BMC Complement Med Ther. 2023 Jul 28;23(1):268. doi: 10.1186/s12906-023-04059-9.

Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus

Pelle MC, Zaffina I, Giofrè F, Pujia R, Arturi F.

Int J Mol Sci. 2023 Jul 11;24(14):11301. doi: 10.3390/ijms241411301.

The GABA system, a new target for medications against cognitive impairment-Associated with neuroactive steroids

Bäckström T, Turkmen S, Das R, Doverskog M, Blackburn TP.

J Intern Med. 2023 Sep;294(3):281-294. doi: 10.1111/joim.13705. Epub 2023 Jul 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias